Access Conditions Pharmaceutical Treatment 
MMJ Recs
MAY 23, 2024
We will be exploring cannabis therapy for chronic conditions. There’s also neuropathic pain, which results from nerve damage, leading to conditions such as shingles or nerve compression. However, for many individuals, these conventional treatments may fall short of providing adequate relief or come with undesirable side effects.
NORML
MARCH 14, 2019
1647 , the Veterans Equal Access Act, which expands medical cannabis access to eligible military veterans. Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. Presently, V.A.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
FEBRUARY 21, 2023
As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.
Cannabis Law Report
AUGUST 10, 2021
We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.
NORML
NOVEMBER 8, 2019
Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us.
NewsMunchies
JULY 10, 2023
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions. AI automation opens up the possibility of faster, cheaper pharmaceuticals. Rate this blog post [Total: 2 Average: 5 ] The post A.I.-Designed
The Cannigma
AUGUST 5, 2022
When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment?
Expert insights. Personalized for you.
105 
Let's personalize your content